Aberrant epigenetic modification-new biomarkers for chemical carcinogenesis
Wang, Q.; Chen, W.
Zhonghua Yu Fang Yi Xue Za Zhi 45(5): 390-392
2011
ISSN/ISBN: 0253-9624 PMID: 21756779 Document Number: 655137
Document emailed within 1 workday
Related Documents
Katsuki, S.; Oui, M.; Takayama, T.; Takahashi, Y.; Shuichi, N.; Niitsu, Y. 1998: Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer Nihon Geka Gakkai Zasshi 99(6): 379-384Alberti, C. 2016: Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications European Review for Medical and Pharmacological Sciences 20(6): 1001-1002
Yuspa, S.H.; Kilkenny, A.; Roop, D.R. 1988: Aberrant differentiation in mouse skin carcinogenesis Iarc Scientific Publications 92: 3-10
Vineis, P. 1997: Biomarkers, low-dose carcinogenesis and dietary exposures European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 6(2): 147-151
Sengupta, A.; Ghosh, S.; Das, S. 2003: Tea can protect against aberrant crypt foci formation during azoxymethane induced rat colon carcinogenesis Journal of Experimental and Clinical Cancer Research: Cr 22(2): 185-191
Khananshvili, D.; Gromet-Elhanan, Z. 1982: Chemical modification of the beta-subunit isolated from a membrane-bound Fo-F1-ATP synthase: modification by 4-chloro-7-nitrobenzofurazan does not inhibit restoration of ATP synthesis or hydrolysis Biochemical and Biophysical Research Communications 108(2): 881-887
Yang, C.; Frenkel, K. 2002: Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 21(4): 331-342
Stjernswärd, J. 1972: Introduction: Modification of immunity and carcinogenesis National Cancer Institute Monograph 35: 149-156
Lutz, W.; Krajewska, B. 1997: Biomarkers in diagnosis of kidney diseases caused by chemical toxins Medycyna Pracy 48(2): 205-213
Miller, R.W. 1971: Transplacental chemical carcinogenesis in man Journal of the National Cancer Institute 47(6): 1169-1171
Likhachev, A.I. 1987: Role of DNA repair in chemical carcinogenesis Voprosy Onkologii 33(1): 3-11
Parks, R.C.; Jones, T.; Banks, A.R.; Hessek, E. 1982: Thioproline: an inhibitor of chemical carcinogenesis Neoplasma 29(5): 535-537
Beliaev, I.I.; Litvinov, I.A. 1981: Modifying factors of chemical carcinogenesis Gigiena i Sanitariia 6: 59-62
Ip, C. 1985: Selenium inhibition of chemical carcinogenesis Federation Proceedings 44(9): 2573-2578
Lang, M.; Pelkonen, O. 1999: Metabolism of xenobiotics and chemical carcinogenesis Iarc Scientific Publications 148: 13-22
Napalkov, N.P.; Anisimov, V.N.; Likhachev, A.J.; Tomatis, L. 1989: 5-Bromodeoxyuridine-induced carcinogenesis and its modification by persistent estrus syndrome, unilateral nephrectomy, and X-irradiation in rats Cancer Research 49(2): 318-323
Miller, J.A.; Miller, E.C. 1971: Chemical carcinogenesis: mechanisms and approaches to its control Journal of the National Cancer Institute 47(3): V-XIV
Brai, M.; Patrucco, A.; Osler, A.G. 1972: Chemical carcinogenesis and humoral antibody synthesis Journal of Immunology 109(2): 317-323
Lankin, V.Z.; Poliakov, V.M.; Arkhangel'skaia, A.V.; Gurevich, S.M. 1979: Lipid peroxide metabolism in chemical carcinogenesis Biulleten' Eksperimental'noi Biologii i Meditsiny 87(3): 270-273
Hermo, H. 1987: Chemical carcinogenesis: tumor initiation and promotion Occupational Medicine 2(1): 1-25